"Help Make a Difference By Participating in Clinical Research People who volunteer to participate in clinical trials are key to the advancement of medical research. Our sites are dedicated to conducting clinical trials with an emphasis on patient care. Our physician investigators and other members of our research teams are extensively trained in different medical subspecialties as well as the complex field of clinical research. We strive to provide our study participants and sponsors a high quality, efficient and care-directed clinical trial experience. Learn more about what we have to offer patients looking to enroll and support drug trials in San Diego!"

During the past decade, eStudySite conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 26 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 23 clinical trials were completed. i.e. 135.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "eStudySite" #1 sponsor was "Pfizer" with 11 trials, followed by "Celgene" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Debiopharm International SA" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "eStudySite" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "eStudySite" are "Migraine" (5 trials), "COVID-19 Pneumonia" (3 trials), "Crohn Disease" (3 trials), "Hepatitis C, Chronic" (3 trials) and "Migraine, With or Without Aura" (3 trials). Many other conditions were trialed in "eStudySite" in a lesser frequency.

Most popular intervention types in "eStudySite" are "Drug" (41 trials), "Biological" (7 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Rimegepant" (4 trials), "Ozanimod" (3 trials), "Linezolid" (2 trials) and "Zavegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "eStudySite" are 44 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "eStudySite". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in eStudySite, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in eStudySite, 5 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".